Özlem Demir

2.6k total citations · 1 hit paper
74 papers, 1.8k citations indexed

About

Özlem Demir is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Özlem Demir has authored 74 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Epidemiology. Recurrent topics in Özlem Demir's work include HIV Research and Treatment (8 papers), RNA modifications and cancer (8 papers) and Cancer-related Molecular Pathways (7 papers). Özlem Demir is often cited by papers focused on HIV Research and Treatment (8 papers), RNA modifications and cancer (8 papers) and Cancer-related Molecular Pathways (7 papers). Özlem Demir collaborates with scholars based in United States, Türkiye and Austria. Özlem Demir's co-authors include Rommie E. Amaro, Jeremy C. Smith, J. Andrew McCammon, Jérôme Baudry, Yinglong Miao, John D. Chodera, Işıl Aksan Kurnaz, Reuben S. Harris, Haldun Müderrisoğlu and Hideki Aihara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Özlem Demir

68 papers receiving 1.7k citations

Hit Papers

Ensemble Docking in Drug Discovery 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Özlem Demir United States 22 1.1k 282 250 213 195 74 1.8k
Ganesha Rai United States 26 1.3k 1.2× 175 0.6× 163 0.7× 153 0.7× 104 0.5× 90 2.2k
Timothy K. Hart United States 19 903 0.8× 174 0.6× 106 0.4× 210 1.0× 157 0.8× 42 1.9k
T.C. Appleby United States 22 775 0.7× 162 0.6× 144 0.6× 272 1.3× 361 1.9× 29 1.5k
Christina Kiel Spain 26 2.6k 2.4× 329 1.2× 509 2.0× 145 0.7× 152 0.8× 60 3.4k
Tove Tuntland United States 25 732 0.7× 214 0.8× 126 0.5× 142 0.7× 151 0.8× 39 1.7k
S. Frank Yan United States 20 1.3k 1.2× 110 0.4× 260 1.0× 200 0.9× 121 0.6× 33 2.2k
Ted Fox United States 18 1.3k 1.1× 261 0.9× 144 0.6× 435 2.0× 198 1.0× 24 2.0k
Stephen P. Chambers United States 18 1.7k 1.5× 193 0.7× 121 0.5× 598 2.8× 294 1.5× 26 2.5k
Maulik Patel United States 25 981 0.9× 218 0.8× 167 0.7× 143 0.7× 113 0.6× 73 1.7k
Jim Zhen Wu United States 31 780 0.7× 200 0.7× 114 0.5× 518 2.4× 409 2.1× 50 2.1k

Countries citing papers authored by Özlem Demir

Since Specialization
Citations

This map shows the geographic impact of Özlem Demir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özlem Demir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özlem Demir more than expected).

Fields of papers citing papers by Özlem Demir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Özlem Demir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özlem Demir. The network helps show where Özlem Demir may publish in the future.

Co-authorship network of co-authors of Özlem Demir

This figure shows the co-authorship network connecting the top 25 collaborators of Özlem Demir. A scholar is included among the top collaborators of Özlem Demir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özlem Demir. Özlem Demir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Demir, Özlem, et al.. (2025). Effect of adenosine triphosphate on methylphenidate-induced oxidative and inflammatory kidney damage in rats. Drug and Chemical Toxicology. 48(6). 1284–1292.
3.
Demir, Özlem, Surl-Hee Ahn, Carla Calvó‐Tusell, et al.. (2025). Regulatory Interactions between APOBEC3B N- and C-Terminal Domains. Journal of Chemical Information and Modeling. 65(7). 3593–3604. 1 indexed citations
4.
Moorthy, Ramkumar, Özlem Demir, Michael A. Carpenter, et al.. (2024). The Impact of Sugar Conformation on the Single-Stranded DNA Selectivity of APOBEC3A and APOBEC3B Enzymes. ACS Chemical Biology. 20(1). 117–127.
5.
Demir, Özlem, et al.. (2023). Protective effect of melatonin and ascorbic acid combination on sepsis‐induced lung injury: An Experimental study. Clinical and Experimental Pharmacology and Physiology. 50(8). 634–646. 13 indexed citations
6.
Shi, Ke, Özlem Demir, Surajit Banerjee, et al.. (2022). Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN. Proceedings of the National Academy of Sciences. 119(9). 85 indexed citations
7.
Barros, Emília P., et al.. (2020). Markov state models and NMR uncover an overlooked allosteric loop in p53. Chemical Science. 12(5). 1891–1900. 33 indexed citations
8.
Wagner, Jeffrey, Özlem Demir, Michael A. Carpenter, et al.. (2018). Determinants of Oligonucleotide Selectivity of APOBEC3B. Journal of Chemical Information and Modeling. 59(5). 2264–2273. 11 indexed citations
9.
Demir, Özlem, et al.. (2018). İİBF Mezun Adaylarının İş Bulma Ümitlerini Etkileyen Faktörler Üzerine Nicel Bir Araştırma. DergiPark (Istanbul University). 9(1). 42–57. 1 indexed citations
10.
Salamango, Daniel J., Jennifer L. McCann, Özlem Demir, et al.. (2018). APOBEC3B Nuclear Localization Requires Two Distinct N-Terminal Domain Surfaces. Journal of Molecular Biology. 430(17). 2695–2708. 36 indexed citations
11.
Lee, John K., Thomas Lee, Jayakanth Kankanala, et al.. (2018). The substrate-binding cap of the UDP-diacylglucosamine pyrophosphatase LpxH is highly flexible, enabling facile substrate binding and product release. Journal of Biological Chemistry. 293(21). 7969–7981. 18 indexed citations
12.
Prabhu, Lakshmi, Lan Chen, Wei Han, et al.. (2017). Development of an AlphaLISA high throughput technique to screen for small molecule inhibitors targeting protein arginine methyltransferases. Molecular BioSystems. 13(12). 2509–2520. 27 indexed citations
13.
Demir, Özlem, et al.. (2017). KLASİK, NEO-KLASİK ve MODERN YÖNETİM YAKLAŞIMLARININ KARŞILAŞTIRILMASINA İLİŞKİN BİR ANALİZ. DergiPark (Istanbul University). 3(2). 119–134. 1 indexed citations
14.
Demir, Özlem, et al.. (2016). Mikrobiyal Yakıt Hücreleri ile Çamur Arıtımı ve Elektrik Üretimi. DergiPark (Istanbul University).
15.
Munoz‐Tello, Paola, Özlem Demir, Kevin J. Cheng, et al.. (2016). RNA Editing TUTase 1: structural foundation of substrate recognition, complex interactions and drug targeting. Nucleic Acids Research. 44(22). 10862–10878. 12 indexed citations
16.
Sørensen, Jesper Givskov, Özlem Demir, Robert V. Swift, Victoria A. Feher, & Rommie E. Amaro. (2014). Molecular Docking to Flexible Targets. Methods in molecular biology. 1215. 445–469. 20 indexed citations
17.
Baronio, Roberta, Özlem Demir, Chiung-Kuang Chen, et al.. (2013). Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53. Nature Communications. 4(1). 1407–1407. 180 indexed citations
18.
Demir, Özlem & Işıl Aksan Kurnaz. (2008). Wildtype Elk-1, but not a SUMOylation mutant, represses egr-1 expression in SH-SY5Y neuroblastomas. Neuroscience Letters. 437(1). 20–24. 17 indexed citations
19.
Gülmez, Öykü, Aylin Yı́ldı́rı́r, U. Bal, et al.. (2007). C-reactive protein levels increase after exercise testing in patients with increased platelet reactivity. Coronary Artery Disease. 18(6). 437–442. 3 indexed citations
20.
Yazar, Enver, Özlem Demir, Muammer Elmas, Ahmet Levent Baş, & Bünyamin Traş. (2002). Phenobarbital Effects on Brain and Liver Tissues Enzyme Activity in Balb/C Mice. Acta Veterinaria Brno. 71(3). 309–312. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026